BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 20055830)

  • 1. Localized cutaneous amyloid at an insulin injection site.
    Lonsdale-Eccles AA; Gonda P; Gilbertson JA; Haworth AE
    Clin Exp Dermatol; 2009 Dec; 34(8):e1027-8. PubMed ID: 20055830
    [No Abstract]   [Full Text] [Related]  

  • 2. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.
    Ansari AM; Osmani L; Matsangos AE; Li QK
    Pathol Res Pract; 2017 Oct; 213(10):1237-1241. PubMed ID: 28935176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.
    Okamura S; Hayashino Y; Kore-Eda S; Tsujii S
    Diabetes Care; 2013 Dec; 36(12):e200. PubMed ID: 24265372
    [No Abstract]   [Full Text] [Related]  

  • 4. Nodular amyloidosis in a diabetic patient with frequent hypoglycemia: sequelae of repeatedly injecting insulin without site rotation.
    Endo JO; Röcken C; Lamb S; Harris RM; Bowen AR
    J Am Acad Dermatol; 2010 Dec; 63(6):e113-4. PubMed ID: 21093656
    [No Abstract]   [Full Text] [Related]  

  • 5. Injection-site skin lesions following pen-injection treatment in a 59-year-old woman with insulin-treated Type 2 diabetes mellitus.
    Winkler G; Sápi Z; Pál B; Molnár L
    Diabet Med; 1997 Dec; 14(12):1078-9. PubMed ID: 9455937
    [No Abstract]   [Full Text] [Related]  

  • 6. Localized insulin-derived amyloidosis in patients with diabetes mellitus: a case report.
    Yumlu S; Barany R; Eriksson M; Röcken C
    Hum Pathol; 2009 Nov; 40(11):1655-60. PubMed ID: 19683329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human recombinant insulin and amyloidosis: an unexpected association.
    Sie MP; van der Wiel HE; Smedts FM; de Boer AC
    Neth J Med; 2010 Mar; 68(3):138-40. PubMed ID: 20308712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcutaneous injection of isophane protamine biosynthetic human insulin induced psoriasis at the injection site.
    Wang P; Ran Y
    Eur J Dermatol; 2011; 21(5):807-8. PubMed ID: 21737378
    [No Abstract]   [Full Text] [Related]  

  • 9. Injection site lipoatrophy: a rare complication of recombinant human insulin.
    Chakraborty PP; Bhattacharjee R
    J Assoc Physicians India; 2010 Oct; 58():630. PubMed ID: 21510114
    [No Abstract]   [Full Text] [Related]  

  • 10. Coexistence of insulin-derived amyloidosis and an overlying acanthosis nigricans-like lesion at the site of insulin injection.
    Kudo-Watanuki S; Kurihara E; Yamamoto K; Mukai K; Chen KR
    Clin Exp Dermatol; 2013 Jan; 38(1):25-9. PubMed ID: 22924529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cutaneous complications of insulin therapy. A drug-induced condition on the decline].
    Piérard-Franchimont C; Hermanns-Lê T; Scheen AJ; Piérard GE
    Rev Med Liege; 2005; 60(5-6):564-5. PubMed ID: 16035329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of suppurative granuloma induced by insulin injection.
    Tanizaki H; Matsumura Y; Tokura Y; Miyachi Y; Kabashima K
    Acta Derm Venereol; 2010 Sep; 90(5):540-1. PubMed ID: 20814643
    [No Abstract]   [Full Text] [Related]  

  • 13. Insulin-derived amyloidosis without a palpable mass at the insulin injection site: A report of two cases.
    Nagase T; Iwaya K; Kogure K; Zako T; Misumi Y; Kikuchi M; Matsumoto K; Noritake M; Kawachi Y; Kobayashi M; Ando Y; Katsura Y
    J Diabetes Investig; 2020 Jul; 11(4):1002-1005. PubMed ID: 31867887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iatrogenic, insulin-dependent, local amyloidosis.
    Störkel S; Schneider HM; Müntefering H; Kashiwagi S
    Lab Invest; 1983 Jan; 48(1):108-11. PubMed ID: 6337294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New Histologic Finding of Amyloid Insulin Bodies at an Insulin Injection Site in a Patient With Diabetes.
    Katzman BD; Traum P; Medline PB
    Am J Dermatopathol; 2018 Jul; 40(7):527-530. PubMed ID: 29135508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid in localized cutaneous amyloidosis: immunofluorescence studies with anti-keratin antiserum especially concerning the difference between systemic and localized cutaneous amyloidosis.
    Masu S; Hosokawa M; Seiji M
    Acta Derm Venereol; 1981; 61(5):381-4. PubMed ID: 6172924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous insulin reaction resembling acanthosis nigricans.
    Fleming MG; Simon SI
    Arch Dermatol; 1986 Sep; 122(9):1054-6. PubMed ID: 3527077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localized insulin-derived amyloidosis: a potential pitfall in the diagnosis of systemic amyloidosis by fat aspirate.
    D'Souza A; Theis JD; Vrana JA; Buadi F; Dispenzieri A; Dogan A
    Am J Hematol; 2012 Nov; 87(11):E131-2. PubMed ID: 23044893
    [No Abstract]   [Full Text] [Related]  

  • 19. Physical signs for the general dental practitioner. Case 74. Lipohypertrophy.
    Bain S
    Dent Update; 2010 May; 37(4):268. PubMed ID: 20527502
    [No Abstract]   [Full Text] [Related]  

  • 20. Case report: acanthosis nigricans resulting from repetitive same-site insulin injections.
    Brodell JD; Cannella JD; Helms SE
    J Drugs Dermatol; 2012 Dec; 11(12):e85-7. PubMed ID: 23377528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.